Related Experiment Video

Updated: Dec 31, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.3K

α5-nAChR modulates melanoma growth through the Notch1 signaling pathway

NingNing Dang1, Xianguang Meng1, Guojing Qin1

  • 1Department of Dermatology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong, China.

Journal of Cellular Physiology
|January 8, 2020
PubMed

Insights

Alpha5-nicotinic acetylcholine receptors (α5-nAChRs) are elevated in melanoma, driving cancer cell proliferation and spread. Inhibiting α5-nAChRs shows promise as a novel melanoma treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • The role of alpha5-nicotinic acetylcholine receptors (α5-nAChRs) in solid cancers is known, but its specific function in melanoma is unclear.
  • Melanoma is a significant form of skin cancer with a need for novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of α5-nAChRs in melanoma cell proliferation, migration, and invasion.
  • To identify downstream signaling pathways regulated by α5-nAChRs in melanoma.

Main Methods:

  • Immunohistochemical analysis of α5-nAChR expression in human melanoma tissues and cell lines.
  • In vitro knockdown of α5-nAChR expression in melanoma cells.
  • Assessment of cell proliferation, migration, and invasion assays.
  • Analysis of PI3K-AKT, ERK1/2, and Notch1 signaling pathways.

Main Results:

  • α5-nAChR expression was significantly upregulated in melanoma tissues and cell lines compared to normal skin.
  • Knockdown of α5-nAChR markedly reduced melanoma cell proliferation, migration, and invasion.
  • Inhibition of α5-nAChR suppressed PI3K-AKT and ERK1/2 signaling.
  • The Notch1 signaling pathway was identified as a downstream target of α5-nAChR in melanoma.

Conclusions:

  • α5-nAChR plays a crucial role in melanoma development and progression.
  • Targeting α5-nAChR represents a potential therapeutic strategy for melanoma treatment.
Keywords:
ERK1/2Notch1PI3Kmelanomaα5-nAChR

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.3K
Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

2.7K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K